AGC Pharma Chemicals is pleased to confirm its participation in BOS Basel 2025, taking place on June 11–12. This event, organized by Bio2Business, is a leading networking platform for biopharma development and manufacturing professionals, designed to foster targeted partnering meetings and industry insight.
BOS Basel focuses on driving meaningful connections between biotech companies and CDMO partners, supporting collaboration across discovery, development, and manufacturing. Its format combines pre-arranged one-to-one meetings, strategic discussions, and presentations from key industry players.
AGC Pharma Chemicals will attend to highlight its offering as a global CDMO specializing in small molecule APIs, with strong expertise in process optimization, regulatory compliance, and HPAPI manufacturing. Our teams in Barcelona and Japan provide end-to-end solutions adapted to the complexity and timelines of modern drug development, visit us at Booth 21.
Events like BOS Basel are essential to strengthen relationships and contribute to the continued evolution of the pharmaceutical outsourcing model through shared knowledge and aligned objectives.
